Literature DB >> 17714604

Evaluation of immunoglobulin G4 subclass antibody in a peptide-based enzyme-linked immunosorbent assay for the serodiagnosis of human fascioliasis.

C Tantrawatpan1, W Maleewong, C Wongkham, S Wongkham, P M Intapan, K Nakashima.   

Abstract

SUMMARYTo improve the diagnosis of human fascioliasis caused by Fasciola gigantica, we developed a peptide-based enzyme-linked immunosorbent assay (peptide-based ELISA) based on the detection of specific IgG4 subclass antibody. Two identified B-cell epitopes of F. gigantica cathepsin L1 were synthesized as single synthetic peptides, acetyl-DKIDWRESGYVTELKDQGNC-carboxamide (peptide L) and acetyl-DKIDWRESGYVTEVKDQGNC-carboxamide (peptide V), and their diagnostic potential was evaluated. The sera of 25 patients infected with F. gigantica, 212 patients with other parasitic infections, 32 cholangiocarcinoma patients and 57 healthy controls were analysed. The sensitivity, specificity, accuracy, and positive and negative predictive values of this assay were the same with both peptides at 100%, 99.7%, 99.7%, 96.2% and 100%, respectively. These highly sensitive and specific peptide-based ELISAs for the detection of specific IgG4 antibody could be useful for laboratory diagnosis of human fascioliasis in future large-scale surveys throughout Southeast Asia where this disease is prevalent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714604     DOI: 10.1017/S0031182007003435

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  7 in total

Review 1.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

2.  Comparative assessment of recombinant and native immunogenic forms of Fasciola hepatica proteins for serodiagnosis of sheep fasciolosis.

Authors:  Kobra Mokhtarian; Ahmad Reza Meamar; Majid Khoshmirsafa; Elham Razmjou; Leila Masoori; Majid Khanmohammadi; Lame Akhlaghi; Reza Falak
Journal:  Parasitol Res       Date:  2017-12-04       Impact factor: 2.289

Review 3.  Immunodiagnosis of Human Fascioliasis: An Update of Concepts and Performances of the Serological Assays.

Authors:  Bahador Sarkari; Samaneh Abdolahi Khabisi
Journal:  J Clin Diagn Res       Date:  2017-06-01

4.  Assessment of Fasciola hepatica glutathione S-transferase as an antigen for serodiagnosis of human chronic fascioliasis.

Authors:  Vasti Aguayo; Bianca Valdes; Ana M Espino
Journal:  Acta Trop       Date:  2018-07-07       Impact factor: 3.112

5.  Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis.

Authors:  Victoria Martínez-Sernández; Laura Muiño; María Jesús Perteguer; Teresa Gárate; Mercedes Mezo; Marta González-Warleta; Antonio Muro; José Manuel Correia da Costa; Fernanda Romarís; Florencio M Ubeira
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

6.  Comparative assessment of ELISAs using recombinant saposin-like protein 2 and recombinant cathepsin L-1 from Fasciola hepatica for the serodiagnosis of human Fasciolosis.

Authors:  Bruno Gottstein; Marianne Schneeberger; Ghalia Boubaker; Bernadette Merkle; Cristina Huber; Markus Spiliotis; Norbert Müller; Teresa Garate; Marcus G Doherr
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

7.  Evaluation of IgG4 subclass antibody detection by peptide-based ELISA for the diagnosis of human paragonimiasis heterotrema.

Authors:  Pewpan M Intapan; Oranuch Sanpool; Penchom Janwan; Porntip Laummaunwai; Nimit Morakote; Yoon Kong; Wanchai Maleewong
Journal:  Korean J Parasitol       Date:  2013-12-31       Impact factor: 1.341

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.